Patient level pooled analysis of 68 500 patients from seven major vitamin D fracture trials in US and Europe.

Publication Type:

Journal Article



BMJ (Clinical research ed.), Volume 340, p.b5463 (2010)


2010, Aged, Aged, 80 and over, Bone Density Conservation Agents, Calcium, Center-Authored Paper, Dietary Supplements, Drug Therapy, Combination, Europe, Female, Fractures, Bone, Hip Fractures, Humans, Male, Public Health Sciences Division, Randomized Controlled Trials as Topic, RECURRENCE, Spinal Fractures, United States, Vitamin D


To identify participants' characteristics that influence the anti-fracture efficacy of vitamin D or vitamin D plus calcium with respect to any fracture, hip fracture, and clinical vertebral fracture and to assess the influence of dosing regimens and co-administration of calcium.